These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 23608947

  • 1. Molecular basis of the PED/PEA15 interaction with the C-terminal fragment of phospholipase D1 revealed by NMR spectroscopy.
    Farina B, Doti N, Pirone L, Malgieri G, Pedone EM, Ruvo M, Fattorusso R.
    Biochim Biophys Acta; 2013 Aug; 1834(8):1572-80. PubMed ID: 23608947
    [Abstract] [Full Text] [Related]

  • 2. Residues 762-801 of PLD1 mediate the interaction with PED/PEA15.
    Doti N, Cassese A, Marasco D, Paturzo F, Sabatella M, Viparelli F, Dathan N, Monti SM, Miele C, Formisano P, Beguinot F, Ruvo M.
    Mol Biosyst; 2010 Oct; 6(10):2039-48. PubMed ID: 20714510
    [Abstract] [Full Text] [Related]

  • 3. Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15.
    Viparelli F, Doti N, Sandomenico A, Marasco D, Dathan NA, Miele C, Beguinot F, Monti SM, Ruvo M.
    Protein Expr Purif; 2008 Jun; 59(2):302-8. PubMed ID: 18420420
    [Abstract] [Full Text] [Related]

  • 4. Discovery of small peptide antagonists of PED/PEA15-D4α interaction from simplified combinatorial libraries.
    Scognamiglio PL, Doti N, Grieco P, Pedone C, Ruvo M, Marasco D.
    Chem Biol Drug Des; 2011 May; 77(5):319-27. PubMed ID: 21294846
    [Abstract] [Full Text] [Related]

  • 5. Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments.
    Farina B, Pirone L, D'Abrosca G, Della Valle M, Russo L, Isernia C, Sassano M, Del Gatto A, Di Gaetano S, Zaccaro L, Malgieri G, Pedone EM, Fattorusso R.
    ACS Chem Biol; 2021 Dec 17; 16(12):2798-2807. PubMed ID: 34825823
    [Abstract] [Full Text] [Related]

  • 6. Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells.
    Viparelli F, Cassese A, Doti N, Paturzo F, Marasco D, Dathan NA, Monti SM, Basile G, Ungaro P, Sabatella M, Miele C, Teperino R, Consiglio E, Pedone C, Beguinot F, Formisano P, Ruvo M.
    J Biol Chem; 2008 Aug 01; 283(31):21769-78. PubMed ID: 18541525
    [Abstract] [Full Text] [Related]

  • 7. Targetting PED/PEA-15 for diabetes treatment.
    Fiory F, Spinelli R, Raciti GA, Parrillo L, D'esposito V, Formisano P, Miele C, Beguinot F.
    Expert Opin Ther Targets; 2017 Jun 01; 21(6):571-581. PubMed ID: 28395542
    [Abstract] [Full Text] [Related]

  • 8. Profound conformational changes of PED/PEA-15 in ERK2 complex revealed by NMR backbone dynamics.
    Twomey EC, Cordasco DF, Wei Y.
    Biochim Biophys Acta; 2012 Dec 01; 1824(12):1382-93. PubMed ID: 22820249
    [Abstract] [Full Text] [Related]

  • 9. Molecular interactions between a diphenyl scaffold and PED/PEA15: Implications for type II diabetes therapeutics targeting PED/PEA15 - Phospholipase D1 interaction.
    Mercurio I, D'Abrosca G, Della Valle M, Malgieri G, Fattorusso R, Isernia C, Russo L, Di Gaetano S, Pedone EM, Pirone L, Del Gatto A, Zaccaro L, Alberga D, Saviano M, Mangiatordi GF.
    Comput Struct Biotechnol J; 2024 Dec 01; 23():2001-2010. PubMed ID: 38770160
    [Abstract] [Full Text] [Related]

  • 10. Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15.
    Cassese A, Raciti GA, Fiory F, Nigro C, Ulianich L, Castanò I, D'Esposito V, Terracciano D, Pastore L, Formisano P, Beguinot F, Miele C.
    PLoS One; 2013 Dec 01; 8(4):e60555. PubMed ID: 23585839
    [Abstract] [Full Text] [Related]

  • 11. NMR backbone dynamics studies of human PED/PEA-15 outline protein functional sites.
    Farina B, Pirone L, Russo L, Viparelli F, Doti N, Pedone C, Pedone EM, Fattorusso R.
    FEBS J; 2010 Oct 01; 277(20):4229-40. PubMed ID: 20825483
    [Abstract] [Full Text] [Related]

  • 12. PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1.
    Fiory F, Parrillo L, Raciti GA, Zatterale F, Nigro C, Mirra P, Falco R, Ulianich L, Di Jeso B, Formisano P, Miele C, Beguinot F.
    PLoS One; 2014 Oct 01; 9(12):e113655. PubMed ID: 25489735
    [Abstract] [Full Text] [Related]

  • 13. Interfering PLD1-PED/PEA15 interaction using self-inhibitory peptides: An in silico study to discover novel therapeutic candidates against type 2 diabetes.
    Baig MH, Kausar MA, Husain FM, Shakil S, Ahmad I, Yadav BS, Saeed M.
    Saudi J Biol Sci; 2019 Jan 01; 26(1):160-164. PubMed ID: 30622421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.